GlobeNewswire 09/11/2023 CytoSorbents Reports Third Quarter 2023 Financial and Operational Results
GlobeNewswire 19/09/2023 ONWARD® Reports 2023 Half Year Results and Business Update
GlobeNewswire 04/09/2023 CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire 31/08/2023 CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
GlobeNewswire 24/08/2023 CIO Leadership: The Steps Needed to Build a High-Performance Culture Will Power the Discussion at th...
TeleTrader 12/12/2022 Europe closes lower as investors brace for CPI data
TeleTrader 06/12/2022 European markets close with losses after data
TeleTrader 01/11/2022 Europe markets higher at open ahead of Fed decision
TeleTrader 31/10/2022 Europe closes mostly higher, inflation hits new record
GlobeNewswire 29/03/2022 Humacyte Reports Fourth Quarter and Year End 2021 Financial Results and Provides Business Update
TeleTrader 25/03/2022 Europe closes mostly higher after US, EU energy deal
GlobeNewswire 14/03/2022 Conformis, Inc. Appoints Denise Pedulla as Chief Legal Officer and Corporate Secretary
GlobeNewswire 01/03/2022 Cara Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
GlobeNewswire 28/02/2022 Humacyte Announces Publication of Positive Long-Term Follow-Up Data from Phase 2 Trial of HAV™ for H...
GlobeNewswire 25/02/2022 Kapruvia® receives positive CHMP opinion for the treatment of moderate-to-severe pruritus in hemodia...
GlobeNewswire 24/02/2022 OPKO Health Reports 2021 Fourth Quarter Business Highlights and Financial Results
GlobeNewswire 24/02/2022 Dentsply Sirona Announces Appointment of Dr. Dorothea Wenzel as New Board Member
GlobeNewswire 03/02/2022 RAYALDEE® Launched in Germany by OPKO Health’s Licensee, VFMCRP
GlobeNewswire 31/01/2022 Humacyte Announces Clinical Case Series Demonstrating Potential of Human Acellular Vessel™ (HAV™) to...
GlobeNewswire 28/01/2022 Humacyte Announces Preclinical Results of Small-Diameter Human Acellular Vessel™ (HAV™) in Coronary ...
TeleTrader 25/01/2022 Europe shrugs off global turmoil, ends higher
TeleTrader 17/01/2022 Europe ends higher after upbeat Chinese data
TeleTrader 17/01/2022 Europe opens higher amid the Forum, COVID data
GlobeNewswire 04/01/2022 Humacyte Announces Presentation of First Preclinical Results of the HAV™ in Coronary Artery Bypass G...
GlobeNewswire 31/12/2021 CIO Leadership: HMG Strategy, the World’s #1 Executive Leadership Network, Looks Ahead to its 15th Y...